SCHEMBL25201869

SCHEMBL25201869

O=[N+]([O-])c1ccncc1B(O)O

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HTT P42858 5/20 0.41
MAPT P10636 4/20 0.41
GAA P10253 2/20 0.40
RAB9A P51151 1/20 0.40
CHUK O15111 1/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 2/20 0.38
HIPK2 Q9H2X6 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
NCOA1 Q15788 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21155430 0.85 ALDH1A1 (0.45) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL29953514 0.78 MAPT (0.52) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL8568179 0.76 ALDH1A1 (0.53) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL171809 0.75 HSD17B10 (0.52) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL488895 0.75 GPR35 (0.47) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL30746531 0.74 TDP1 (0.39) ALDH1A1HTTGAAKMT2AMEN1
SCHEMBL20604640 0.74 TDP1 (0.39) ALDH1A1HTTGAAKMT2AMEN1
SCHEMBL8560647 0.74 HTT (0.50) ALDH1A1HTTMAPTGAAKMT2A
SCHEMBL27546560 0.73 KMT2A (0.49) ALDH1A1HTTMAPTGAARAB9A
Ammonia Solution, Strong SCHEMBL27551880 0.73 HSD17B10 (0.50) ALDH1A1HTTMAPTGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250025581-A1 Medical Imaging of Glycogen Synthase Kinase-3 with a PET Probe MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2025-01-23 US disclosed
EP-4433454-A2 MEDICAL IMAGING OF GLYCOGEN SYNTHASE KINASE-3 WITH A PET PROBE Mayo Foundation for Medical Education and Research (US) 2024-09-25 EP disclosed
WO-2023091697-A2 MEDICAL IMAGING OF GLYCOGEN SYNTHASE KINASE-3 WITH A PET PROBE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2023-05-25 WO disclosed
CN-113717181-B Host material, organic photoelectric device and display or lighting device 浙江华显光电科技有限公司 2022-09-30 CN disclosed
CN-113817462-B Host material, organic photoelectric device and display or lighting device 浙江华显光电科技有限公司 2022-09-30 CN disclosed
CN-113817462-A Host material, organic photoelectric device and display or lighting device 浙江华显光电科技有限公司 2021-12-21 CN disclosed
CN-113717181-A Host material, organic photoelectric device and display or lighting device 浙江华显光电科技有限公司 2021-11-30 CN disclosed
CN-113444097-A Tri-carbazole derivative, organic photoelectric device, and display or lighting device 浙江华显光电科技有限公司 2021-09-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250025581-A1 Medical Imaging of Glycogen Synthase Kinase-3 with a PET Probe GYS2, GYS1, PKN3 ALDH1A1 3548/4885HTT 1896/4885MAPT 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.